Literature DB >> 20107017

The HR motif in the RNA-dependent RNA polymerase L protein of Chandipura virus is required for unconventional mRNA-capping activity.

Tomoaki Ogino1, Amiya K Banerjee.   

Abstract

Chandipura virus (CHPV) is an emerging human pathogen associated with acute encephalitis and is related closely to vesicular stomatitis virus (VSV), a prototype rhabdovirus. Here, we demonstrate that the RNA polymerase L protein of CHPV exhibits a VSV-like RNA:GDP polyribonucleotidyltransferase (PRNTase) activity, which transfers the 5'-monophosphorylated (p-) viral mRNA start sequence to GDP to produce a capped RNA, and that the conserved HR motif in the CHPV L protein is essential for the PRNTase activity. Interestingly, the CHPV L protein was found to form two distinct SDS-resistant complexes with the CHPV mRNA and leader RNA start sequences; mutations in the HR motif significantly reduced the formation of the former complex (a putative covalent enzyme-pRNA intermediate in the PRNTase reaction), but not the latter complex. These results suggest that the rhabdoviral L proteins universally use the active-site HR motif for the PRNTase reaction at the step of the enzyme-pRNA intermediate formation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20107017      PMCID: PMC2855774          DOI: 10.1099/vir.0.019307-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  12 in total

Review 1.  Structure, mechanism, and evolution of the mRNA capping apparatus.

Authors:  S Shuman
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  2001

2.  Complete genome sequences of Chandipura and Isfahan vesiculoviruses.

Authors:  A C Marriott
Journal:  Arch Virol       Date:  2004-12-21       Impact factor: 2.574

3.  Determination of the complete genomic sequence and analysis of the gene products of the virus of Spring Viremia of Carp, a fish rhabdovirus.

Authors:  Bernd Hoffmann; Heike Schütze; Thomas C Mettenleiter
Journal:  Virus Res       Date:  2002-03-20       Impact factor: 3.303

4.  Unconventional mechanism of mRNA capping by the RNA-dependent RNA polymerase of vesicular stomatitis virus.

Authors:  Tomoaki Ogino; Amiya K Banerjee
Journal:  Mol Cell       Date:  2007-01-12       Impact factor: 17.970

5.  Genome organization and transcription strategy in the complex GNS-L intergenic region of bovine ephemeral fever rhabdovirus.

Authors:  S M McWilliam; K Kongsuwan; J A Cowley; K A Byrne; P J Walker
Journal:  J Gen Virol       Date:  1997-06       Impact factor: 3.891

6.  Histidine-mediated RNA transfer to GDP for unique mRNA capping by vesicular stomatitis virus RNA polymerase.

Authors:  Tomoaki Ogino; Satya P Yadav; Amiya K Banerjee
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-08       Impact factor: 11.205

7.  Molecular diversity of the Lyssavirus genus.

Authors:  H Bourhy; B Kissi; N Tordo
Journal:  Virology       Date:  1993-05       Impact factor: 3.616

8.  Formation of guanosine(5')tetraphospho(5')adenosine cap structure by an unconventional mRNA capping enzyme of vesicular stomatitis virus.

Authors:  Tomoaki Ogino; Amiya K Banerjee
Journal:  J Virol       Date:  2008-05-21       Impact factor: 5.103

9.  RNA transcription by the virion polymerases of five rhabdoviruses.

Authors:  S H Chang; E Hefti; J F Obijeski; D H Bishop
Journal:  J Virol       Date:  1974-03       Impact factor: 5.103

Review 10.  Viral and cellular mRNA capping: past and prospects.

Authors:  Y Furuichi; A J Shatkin
Journal:  Adv Virus Res       Date:  2000       Impact factor: 9.937

View more
  26 in total

Review 1.  An unconventional pathway of mRNA cap formation by vesiculoviruses.

Authors:  Tomoaki Ogino; Amiya K Banerjee
Journal:  Virus Res       Date:  2011-09-16       Impact factor: 3.303

Review 2.  In vitro capping and transcription of rhabdoviruses.

Authors:  Tomoaki Ogino
Journal:  Methods       Date:  2012-06-08       Impact factor: 3.608

Review 3.  Interplay between innate immunity and negative-strand RNA viruses: towards a rational model.

Authors:  Denis Gerlier; Douglas S Lyles
Journal:  Microbiol Mol Biol Rev       Date:  2011-09       Impact factor: 11.056

Review 4.  Polymerases of paramyxoviruses and pneumoviruses.

Authors:  Rachel Fearns; Richard K Plemper
Journal:  Virus Res       Date:  2017-01-16       Impact factor: 3.303

5.  5'-Phospho-RNA Acceptor Specificity of GDP Polyribonucleotidyltransferase of Vesicular Stomatitis Virus in mRNA Capping.

Authors:  Minako Ogino; Tomoaki Ogino
Journal:  J Virol       Date:  2017-02-28       Impact factor: 5.103

6.  The inability of wild-type rabies virus to activate dendritic cells is dependent on the glycoprotein and correlates with its low level of the de novo-synthesized leader RNA.

Authors:  Yang Yang; Ying Huang; Clement W Gnanadurai; Shengbo Cao; Xueqin Liu; Min Cui; Zhen F Fu
Journal:  J Virol       Date:  2014-12-03       Impact factor: 5.103

7.  The L-VP35 and L-L interaction domains reside in the amino terminus of the Ebola virus L protein and are potential targets for antivirals.

Authors:  Martina Trunschke; Dominik Conrad; Sven Enterlein; Judith Olejnik; Kristina Brauburger; Elke Mühlberger
Journal:  Virology       Date:  2013-04-11       Impact factor: 3.616

8.  Sequence-function analysis of the Sendai virus L protein domain VI.

Authors:  Andrea M Murphy; Megan Moerdyk-Schauwecker; Arcady Mushegian; Valery Z Grdzelishvili
Journal:  Virology       Date:  2010-07-06       Impact factor: 3.616

9.  Analysis of the dark proteome of Chandipura virus reveals maximum propensity for intrinsic disorder in phosphoprotein.

Authors:  Nishi R Sharma; Kundlik Gadhave; Prateek Kumar; Mohammad Saif; Md M Khan; Debi P Sarkar; Vladimir N Uversky; Rajanish Giri
Journal:  Sci Rep       Date:  2021-06-24       Impact factor: 4.379

10.  The respiratory syncytial virus polymerase has multiple RNA synthesis activities at the promoter.

Authors:  Sarah L Noton; Laure R Deflubé; Chadene Z Tremaglio; Rachel Fearns
Journal:  PLoS Pathog       Date:  2012-10-18       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.